Health Minister Ong Ye Kung disclosed this while speaking at a United Nations General Assembly side event on outbreak preparedness and response in New York on Wednesday.
According to a statement by Singapore’s Ministry of Health, Ong said mRNA technology could provide greater flexibility and shorten development and production timelines in responding to novel and rapidly spreading diseases.
He said the pilot would also serve a peacetime need while helping Singapore develop adaptable vaccine manufacturing capabilities.
Ong said Singapore was aligning its vaccine development efforts under its Prepvax research initiative with the Coalition for Epidemic Preparedness Innovations’ 100-day mission.
The mission aims to develop vaccines for initial authorisation and scale-up within 100 days of identifying a pandemic threat.
He said Singapore was also collaborating with companies including Sanofi, GSK, Moderna and Thermo Fisher Scientific.
According to him, the country is participating in Wellcome Leap’s RNA Readiness and Response Global Network, which is exploring continuous flow RNA manufacturing to reduce production bottlenecks.
Discussion0